Extract from :
暂无分享,去创建一个
J F Potter | P S Sever | B. Williams | J. Potter | N. Poulter | P. Sever | G. Mcinnes | M. Brown | S. Thom | M J Brown | M. Davis | M Davis | B Williams | N R Poulter | G T McInnes | S McG Thom | JF Potter | M. Brown | Morris J. Brown | B. Williams | NR Poulter | MJ Brown | GT McInnes | PS Sever | B. Williams | NR Poulter | MJ Brown | M. Davis | GT McInnes | PS Sever | S. M. Thom
[1] A. Folsom,et al. Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women , 1993 .
[2] C. Isles,et al. Malignant hypertension in women of childbearing age and its relation to the contraceptive pill. , 1987, British medical journal.
[3] D. Levy,et al. Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease , 2001 .
[4] N. Hollenberg. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. , 2004, Current hypertension reports.
[5] A. Carlsson,et al. Very high blood pressure in acute stroke , 1990, Journal of internal medicine.
[6] J. Swales. Textbook of hypertension , 1994 .
[7] Jiang He,et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. , 2002, JAMA.
[8] Jiang He,et al. Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2001, Hypertension.
[9] P. Rubin. Measuring diastolic blood pressure in pregnancy , 1996, BMJ.
[10] B. Sibai. Treatment of hypertension in pregnant women. , 1996, The New England journal of medicine.
[11] B. Williams,et al. Microalbuminuria in essential hypertension: redefining the threshold. , 2002, Journal of hypertension.
[12] J. Laragh,et al. VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk. , 2004, American journal of hypertension.
[13] R. Maheswaran,et al. Effectiveness of advice to reduce alcohol consumption in hypertensive patients. , 1992, Hypertension.
[14] Gail D Pearson,et al. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy , 2003, Hypertension in pregnancy.
[15] D. Grobbee,et al. EFFECT OF CALCIUM SUPPLEMENTATION ON DIASTOLIC BLOOD PRESSURE IN YOUNG PEOPLE WITH MILD HYPERTENSION , 1986, The Lancet.
[16] G. Lip,et al. Blood pressure measurement , 2001, BMJ : British Medical Journal.
[17] N. Taub,et al. The Predictive Role of 24-Hour Compared to Casual Blood Pressure Levels on Outcome following Acute Stroke , 1997 .
[18] L. Trupin,et al. Change in Paternity: A Risk Factor for Preeclampsia in Multiparas , 1996, Epidemiology.
[19] J. Tuomilehto,et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.
[20] J. Vandenbroucke,et al. Oral Contraceptives , Hormone Replacement Therapy and , 2022 .
[21] G. Lip,et al. Atenolol and fetal growth in pregnancies complicated by hypertension. , 1999, American journal of hypertension.
[22] R. Withers,et al. Physical activity and cardiovascular risk factors: effect of advice from an exercise specialist in Australian general practice , 2000, The Medical journal of Australia.
[23] G. Bakris,et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] B Neal,et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. , 1999, Clinical and experimental hypertension.
[25] M. Kikuya,et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study , 2002, Journal of hypertension.
[26] J. Manson,et al. Smoking Cessation and Time Course of Decreased Risks of Coronary Heart Disease in Middle-Aged Women , 1994 .
[27] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[28] H. Wallenburg,et al. Prevention of pre-eclampsia: status and perspectives 2000. , 2001, European journal of obstetrics, gynecology, and reproductive biology.
[29] R. Beaglehole,et al. HYPERTENSION Exercise for hypertension , 1993, The Lancet.
[30] M. Lishner,et al. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. , 1996, Archives of internal medicine.
[31] C. Redman,et al. Comparative Risk-Benefit Assessment of Drugs Used in the Management of Hypertension in Pregnancy , 1992, Drug safety.
[32] G. Dekker,et al. Primary, secondary, and tertiary prevention of pre-eclampsia , 2001, The Lancet.
[33] D J Reda,et al. Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo , 1993 .
[34] H. Morita,et al. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. , 2003, Lancet.
[35] H. Parving,et al. Prevention of diabetic renal disease with special reference to microalbuminuria , 1995, The Lancet.
[36] Sarah Parish,et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.
[37] The Gisen Group. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy , 1997, The Lancet.
[38] P Omvik,et al. How smoking affects blood pressure. , 1996, Blood pressure.
[39] T. Lancaster,et al. The new NHS: Medical students say no , 1998 .
[40] J. Staessen,et al. A meta-analysis of outcome trials in elderly hypertensives. , 1992, Journal of hypertension.
[41] G. Guyatt,et al. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. , 1999, American journal of hypertension.
[42] Diederick E. Grobbee,et al. Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2003, Hypertension.
[43] A. Piccoli,et al. Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension. , 1993, Hypertension.
[44] J. Pell,et al. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.
[45] P Degoulet,et al. Do physicians estimate reliably the cardiovascular risk of hypertensive patients?. , 1995, Medinfo. MEDINFO.
[46] Peter W de Leeuw,et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. , 2003, The New England journal of medicine.
[47] N. Fineberg,et al. Salt Sensitivity and Resistance of Blood Pressure Age and Race As Factors in Physiological Responses , 1991, Hypertension.
[48] H. Morita,et al. RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial , 2003, The Lancet.
[49] G. Striker. Modification of diet in renal disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[50] D. Lawlor,et al. Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis , 2002, The Lancet.
[51] L. Niskanen,et al. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project. , 2001, Diabetes care.
[52] C. Nowson,et al. Effect of Calcium Carbonate on Blood Pressure in Normotensive and Hypertensive People , 1989, Hypertension.
[53] A. Carter,et al. Hypotensive therapy in stroke survivors. , 1970, Lancet.
[54] R. Cooper,et al. Hypertension Treatment and Control in Five European Countries, Canada, and the United States , 2004, Hypertension.
[55] E. Barrett-Connor. Clinical review 162: cardiovascular endocrinology 3: an epidemiologist looks at hormones and heart disease in women. , 2003, The Journal of clinical endocrinology and metabolism.
[56] H. Diener,et al. The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors , 2003, Stroke.
[57] T. Beard,et al. RANDOMISED CONTROLLED TRIAL OF A NO-ADDED-SODIUM DIET FOR MILD HYPERTENSION , 1982, The Lancet.
[58] N. Chaturvedi. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria , 1997, The Lancet.
[59] Majid Ezzati,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[60] G A Colditz,et al. A meta-analysis of physical activity in the prevention of coronary heart disease. , 1990, American journal of epidemiology.
[61] Tom Greene,et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.
[62] G. Davey Smith,et al. Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: results from a prospective cohort study of Scottish men with 21 years of follow up , 1999, BMJ.
[63] G. Kelley,et al. Progressive resistance exercise and resting blood pressure : A meta-analysis of randomized controlled trials. , 2000, Hypertension.
[64] D. Johnston,et al. Effect of stress management on blood pressure in mild primary hypertension. , 1993, BMJ.
[65] A. Hughes,et al. Pre-eclampsia, antiretroviral therapy, and immune reconstitution , 2002, The Lancet.
[66] Jm Roberts,et al. Pathogenesis and genetics of pre-eclampsia , 2001, The Lancet.
[67] Morris J. Brown,et al. Matching the right drug to the right patient in essential hypertension , 2001, Heart.
[68] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[69] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[70] E. DeLong,et al. Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension. , 1987, Hypertension.
[71] A. Levey,et al. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. , 1997, Annals of internal medicine.
[72] B. Gavish,et al. Treating hypertension with a device that slows and regularises breathing: a randomised, double-blind controlled study , 2001, Journal of Human Hypertension.
[73] Yutaka Imai,et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults , 2002, Blood pressure monitoring.
[74] S. Rosenberg. Combined modality therapy of cancer. What is it and when does it work? , 1985, The New England journal of medicine.
[75] Michael D. Brown,et al. The Role of Exercise Training in the Treatment of Hypertension , 2000, Sports medicine.
[76] P. Mehler,et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. , 2002, Kidney international.
[77] Thomas Hedner,et al. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study , 2000, The Lancet.
[78] P. Whelton,et al. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. , 2000, Hypertension.
[79] A. Folsom,et al. Association of Hormone-Replacement Therapy With Various Cardiovascular Risk Factors in Postmenopausal Women , 1993 .
[80] L. Lindholm. Antihypertensive treatment in the elderly. , 1996, Clinical and experimental hypertension.
[81] G Parati,et al. Blood pressure measuring devices: recommendations of the European Society of Hypertension , 2001, BMJ : British Medical Journal.
[82] P. Sandercock,et al. Long‐term Survival After First‐Ever Stroke: The Oxfordshire Community Stroke Project , 1993, Stroke.
[83] G Koren,et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis , 2000, The Lancet.
[84] E. Barrett-Connor,et al. Hormone replacement therapy, heart disease, and other considerations. , 1998, Annual review of public health.
[85] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[86] P. Sandercock,et al. Blood Pressure and Clinical Outcomes in the International Stroke Trial , 2002, Stroke.
[87] K. Borch-Johnsen,et al. Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study , 2003, The Lancet.
[88] J. Keaney,et al. Antioxidants and atherosclerotic heart disease. , 1997, The New England journal of medicine.
[89] J. Morris,et al. Exercise in leisure time: coronary attack and death rates. , 1990, British heart journal.
[90] Jixian Wang,et al. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies , 2002, BMJ : British Medical Journal.
[91] H. Tunstall-Pedoe,et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.
[92] G. O'Sullivan,et al. Validation of the Welch Allyn ‘Vital Signs’ blood pressure measurement device in pregnancy and pre‐eclampsia , 2003, BJOG : an international journal of obstetrics and gynaecology.
[93] J. Potter,et al. Blood pressure in acute stroke. , 2004, Age and ageing.
[94] G. Prescott,et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study , 2003, BMJ : British Medical Journal.
[95] J. Swales. Some think him ill-tempered and queer.. , 1989 .
[96] G. Bray,et al. Effects of Diet and Sodium Intake on Blood Pressure: Subgroup Analysis of the DASH-Sodium Trial , 2001, Annals of Internal Medicine.
[97] B Neal,et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials , 2000, The Lancet.
[98] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[99] Susan R. Johnson,et al. Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial , 1995 .
[100] C. Bulpitt,et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. , 1993, BMJ.
[101] Karla Kerlikowske,et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials , 1999, The Lancet.
[102] R. Peto,et al. Overview of randomised trials of diuretics in pregnancy. , 1985, British medical journal.
[103] Pats,et al. Post-stroke antihypertensive treatment study. A preliminary result. , 1995, Chinese medical journal.
[104] R. Schrier,et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. , 2000, Diabetes care.
[105] D. Reda,et al. Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. , 1995, American journal of hypertension.
[106] B. Brenner,et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. , 2003, Archives of internal medicine.
[107] D. Beevers,et al. The management of hypertensive disease in black patients. , 1999, QJM : monthly journal of the Association of Physicians.
[108] S. Yusuf. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .
[109] G. Lip,et al. Ethnic differences in blood pressure and the prevalence of hypertension in England , 2002, Journal of Human Hypertension.
[110] T. Hulsey,et al. Association of pregnancy-induced-hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception , 1996, The Lancet.
[111] JoAnn E. Manson,et al. Effects of estrogen plus progestin on health-related quality of life. , 2003, The New England journal of medicine.
[112] G. Bray,et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.
[113] Bruce H. R. Wolffenbuttel,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.
[114] L. Chesley. Hypertension in pregnancy: definitions, familial factor, and remote prognosis. , 1980, Kidney international.
[115] A. Dobson,et al. How soon after quitting smoking does risk of heart attack decline? , 1991, Journal of clinical epidemiology.
[116] R. Holman,et al. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). , 2001, Clinical science.
[117] D. Henderson-smart,et al. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review , 2001, BMJ : British Medical Journal.
[118] R. Collins,et al. Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial , 2001, Journal of hypertension.
[119] P. Whelton,et al. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. , 1999, Hypertension.
[120] Jan A Staessen,et al. Cardiovascular protection and blood pressure reduction: a meta-analysis , 2001, The Lancet.
[121] Tom Fahey,et al. Predictive accuracy of the Framingham coronary risk score in British men:prospective cohort study , 2003, BMJ : British Medical Journal.
[122] Hans L Hillege,et al. Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.
[123] M. Taub. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men , 1995 .
[124] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[125] T. Pickering,et al. Home blood pressure monitoring. , 2000 .
[126] J. Laragh. Renin system analysis defines the special value of combination antihypertensive therapy using an antirenin agent (CEI) with a long-acting calcium channel blocker (CCB). , 1998, American journal of hypertension.
[127] T. Hedner,et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study , 1999, The Lancet.
[128] A. Coats. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[129] A. Dominiczak,et al. Better blood pressure control: how to combine drugs , 2003, Journal of Human Hypertension.
[130] AndrewJ. S. Coats. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.
[131] J. D. Wallace,et al. Blood pressure after stroke. , 1981, JAMA.
[132] Norman M. Kaplan,et al. Kaplan's Clinical Hypertension , 2002 .
[133] G. Bray,et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.
[134] R. Bigazzi,et al. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension , 1998, Journal of hypertension.
[135] G. Navis,et al. ACE-inhibitors: panacea for progressive renal disease? , 1997, The Lancet.
[136] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[137] Jan A Staessen,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.
[138] Simpson Ma. A mythology of medical education. , 1974 .
[139] R. Collins,et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial , 2003, The Lancet.
[140] B. Davis,et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.
[141] S. Ebrahim,et al. Systematic review of long term effects of advice to reduce dietary salt in adults , 2002, BMJ : British Medical Journal.
[142] Teven,et al. EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES AND NEPHROPATHY EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY , 2001 .
[143] G. Sagnella. Why is plasma renin activity lower in populations of African origin? , 2001, Journal of Human Hypertension.
[144] J. Shepherd,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial , 2003 .
[145] 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension , 2004, Heart Drug.
[146] S. Gutnikov,et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis , 2003, The Lancet.
[147] John S Yudkin,et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.
[148] E. Schiffrin,et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. , 2003, Archives of internal medicine.
[149] Jiang He,et al. Effect of Aerobic Exercise on Blood Pressure , 2002, Annals of Internal Medicine.
[150] K. Fox,et al. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.
[151] R. Collins,et al. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[152] C. Reid,et al. Interactions between the effects of exercise and weight loss on risk factors, cardiovascular haemodynamics and left ventricular structure in overweight subjects , 1994, Journal of hypertension.
[153] F. Nieto,et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus , 2000 .
[154] Emanuela Falaschetti,et al. Association Between Smoking and Blood Pressure: Evidence From the Health Survey for England , 2001, Hypertension.
[155] R. Mulcahy,et al. Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. , 1983, British medical journal.
[156] B. Williams. Epidemiology and pathogenesis of hypertension in people with diabetes mellitus , 2003 .
[157] G. Beck,et al. The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .
[158] W. Kernan. Re: Evaluation of acute candesartan cilexetil therapy in stroke survivors. , 2003, Stroke.
[159] M. Fujii,et al. Effects of Long‐Acting Calcium Channel Antagonists on Neurohumoral Factors: Comparison of Nifedipine Coat‐Core with Amlodipine , 2003, Journal of cardiovascular pharmacology.
[160] J. Whitworth,et al. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension , 2003, Journal of hypertension.
[161] B. Sibai,et al. Low-dose aspirin to prevent preeclampsia in women at high risk , 1998 .
[162] E. Nelson,et al. The treatment of mild hypertension study. , 1993, JAMA.
[163] J. Kirkpatrick. Albuminuria and Risk of Cardiovascular Events , Death , and Heart Failure in Diabetic and Nondiabetic Individuals , 2002 .
[164] C. Viscoli,et al. A clinical trial of estrogen-replacement therapy after ischemic stroke. , 2001, The New England journal of medicine.
[165] C. Palmer,et al. Influence of diabetes and type of hypertension on response to antihypertensive treatment. , 2000, Hypertension.
[166] B. Williams. Drug treatment of hypertension , 1954, BMJ : British Medical Journal.
[167] B. Williams. The unique vulnerability of diabetic subjects to hypertensive injury , 1999, Journal of Human Hypertension.
[168] M. Laakso,et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.
[169] S. Textor,et al. Resistant Hypertension: Comparing Hemodynamic Management to Specialist Care , 2002, Hypertension.
[170] Illiam,et al. THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION , 2000 .
[171] S. Yusuf,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[172] R. Priest,et al. The hypertensive disorders of pregnancy , 1995 .
[173] A. Levey,et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. , 1997, Hypertension.
[174] D. Reda,et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. , 1995, The New England journal of medicine.
[175] N. Poulter,et al. Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994 , 1997, Journal of hypertension.
[176] B. Neal. The Blood Pressure Lowering Treatment Trialists' Collaboration , 2001 .
[177] M. Keirse,et al. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. , 1991, Obstetrics and gynecology.
[178] Ailsa E Gebbie,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. JAMA 2002; 288(3): 321-333 , 2002, Journal of Family Planning and Reproductive Health Care.
[179] R. Collins,et al. Heart Protection Study , 2003, The Lancet.
[180] F. Luft. Mechanisms and Cardiovascular Damage in Hypertension , 2001 .
[181] H. Parving,et al. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study , 1997, BMJ.
[182] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. , 2000, American journal of obstetrics and gynecology.
[183] R. Beaglehole,et al. Exercise for hypertension. , 1993, Lancet.
[184] G. Mcinnes. ALLHAT: a saga of missed opportunities , 2003, Journal of Human Hypertension.
[185] J. Nagy,et al. Prevention and treatment of diabetic nephropathy. , 2005, Diabetes research and clinical practice.
[186] B. Williams. Westernised Asians and cardiovascular disease: nature or nurture? , 1995, The Lancet.
[187] M. Schroll,et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. , 2000, Hypertension.
[188] N. Markandu,et al. Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. , 1998, Hypertension.
[189] F. Mee,et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society , 2000, BMJ : British Medical Journal.
[190] L. Wilkins. Trial of Secondary Prevention With Atenolol After Transient Ischemic Attack or Nondisabling Ischemic Stroke , 1993, Stroke.
[191] K. Asplund,et al. The Prognostic Value of Admission Blood Pressure in Patients With Acute Stroke , 1993, Stroke.
[192] N. Poulter,et al. Improved Hypertension Management and Control: Results From the Health Survey for England 1998 , 2001, Hypertension.
[193] C. Lewis,et al. Treatment of Mild Hypertension Study: Final Results , 1993 .
[194] B. Karlberg,et al. Effects of modulators of the renin—angiotensin—aldosterone system on cough , 1994, Journal of hypertension.
[195] C. Furberg,et al. HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data. , 1998, Atherosclerosis.
[196] Giuseppe Mancia,et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) , 2000, The Lancet.
[197] J. Geleijnse,et al. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension , 1994, BMJ.
[198] T. MacDonald,et al. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. , 1999, British journal of clinical pharmacology.
[199] M. Law,et al. An analysis of the effectiveness of interventions intended to help people stop smoking. , 1995, Archives of internal medicine.
[200] F. Luft,et al. Workshop: mechanisms and cardiovascular damage in hypertension. , 2001, Hypertension.
[201] Gianfranco Parati,et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. , 1999 .
[202] S. Anderssen,et al. Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES). , 1995, Blood pressure.
[203] M. Marmot,et al. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians , 1991, The Lancet.
[204] C. Bulpitt. Hypertension in the very elderly. , 1994, Journal of human hypertension.
[205] A. Hofman,et al. Study on COgnition and Prognosis in the Elderly (SCOPE). , 1999, Blood pressure.
[206] TREATING MILD HYPERTENSION - THE OTHER SIDE OF THE COIN , 1983 .
[207] B. Williams,et al. Insulin resistance: the shape of things to come , 1994, The Lancet.
[208] Steven Snapinn,et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol , 2002, The Lancet.
[209] B. Materson. High blood pressure in African Americans. , 2003, Archives of internal medicine.
[210] P. Whelton,et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. , 1997, JAMA.
[211] V. Athyros,et al. Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention , 2002, Current medical research and opinion.
[212] Pats-Collaborating-Group-. Post-stroke antihypertensive treatment study. A preliminary result , 1995 .
[213] T. Mori,et al. Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. , 1998, Hypertension.
[214] F. Turnbull. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.
[215] Bma Nhs Confederation. Investing in General Practice: The New General Medical Services Contract , 2003 .
[216] R S Paffenbarger,et al. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. , 1993, The New England journal of medicine.
[217] Morris J. Brown. Review: Implications from hypertension outcome trials for the management of patients with hypertension and diabetes: , 2003 .
[218] R. Senior,et al. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. , 1998, Circulation.
[219] G. Mancia,et al. The ALLHAT trial: a verdict or a challenge? , 2003, Journal of hypertension.
[220] A. Carlsson,et al. Blood pressure after stroke. A one-year follow-up study. , 1993, Stroke.
[221] H. Parving. Initiation and progression of diabetic nephropathy. , 1996, The New England journal of medicine.
[222] L. Poston,et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial , 1999, The Lancet.
[223] G. Smith,et al. Scottish men with 21 years of follow up results from a prospective cohort study of causes , coronary heart disease , and stroke : Alcohol consumption and mortality from all , 1999 .
[224] P. Nihoyannopoulos,et al. Central role of echocardiography in the diagnosis and assessment of heart failure. British Society of Echocardiography. , 1998, Heart.
[225] G. Mancia,et al. Systolic and diastolic blood pressure control in antihypertensive drug trials. , 2002, Journal of hypertension.
[226] J. Potter,et al. Factors Affecting Changes in Blood Pressure After Acute Stroke , 1994, Stroke.
[227] J. Higgins,et al. Blood-pressure measurement and classification in pregnancy , 2001, The Lancet.
[228] B. Olofsson,et al. Atenolol in Secondary Prevention after Stroke , 1995 .
[229] P. Whelton,et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.
[230] S Hulley,et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.
[231] C. Wolfe,et al. Variations in case fatality and dependency from stroke in western and central Europe. The European BIOMED Study of Stroke Care Group. , 1999, Stroke.
[232] M. Marmot,et al. Controlled trial of biofeedback-aided behavioural methods in reducing mild hypertension. , 1981, British medical journal.
[233] L. Hansson,et al. Antihypertensive efficacy and side effects of three beta‐blockers and a diuretic in elderly hypertensives: a report from the STOP‐Hypertension study , 1992, Journal of hypertension.
[234] C. Redman,et al. FINAL REPORT OF STUDY ON HYPERTENSION DURING PREGNANCY: THE EFFECTS OF SPECIFIC TREATMENT ON THE GROWTH AND DEVELOPMENT OF THE CHILDREN , 1982, The Lancet.
[235] M. Nieminen,et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. , 2002, JAMA.
[236] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[237] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[238] Gram Jb,et al. The Scandinavian Simvastatin Survival Study (4S) , 1995 .
[240] K Rodahl,et al. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. , 1993, The New England journal of medicine.
[241] D. Altman,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[242] M. Marmot,et al. Can general practitioners use training in relaxation and management of stress to reduce mild hypertension? , 1988, British medical journal.
[243] J. Laragh,et al. VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk , 2003 .
[244] I. U. Haq,et al. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men , 1999, Heart.
[245] N. Atkins,et al. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. , 1999, Hypertension.
[247] D. Levy,et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.
[248] J. Neaton,et al. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.
[249] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[250] Eaft Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.
[251] J. Cutler. Calcium-channel blockers for hypertension--uncertainty continues. , 1998, The New England journal of medicine.
[252] R. Vandongen,et al. Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men. , 1992, Hypertension.
[253] A. Gotto,et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.
[254] U. Goldbourt,et al. Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?: A Systematic Review , 1998 .
[255] White Gb,et al. Letter: Viruses and gastroenteritis. , 1975, Lancet.
[256] P. Macfarlane,et al. West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .
[257] C. Reid,et al. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. , 2003, The New England journal of medicine.
[258] N J Wald,et al. A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.
[259] M. Nieminen,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[260] M. Pollock,et al. Moderate- and high-intensity exercise lowers blood pressure in normotensive subjects 60 to 79 years of age. , 1994, The American journal of cardiology.
[261] Bell Ds. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. , 2000 .
[262] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[263] R. Collins,et al. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.
[264] Edward M. Hitchcock,et al. Alcohol consumption--a risk factor for hemorrhagic and non-hemorrhagic stroke. , 1991, The American journal of medicine.
[265] Y. Kawano,et al. Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. , 1998, Hypertension.
[266] M. Burnier,et al. Isolated office hypertension: a prehypertensive state? , 1996, Journal of hypertension.
[267] A. Hofman,et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.
[268] C. Goodman. Association for the Advancement of Medical Instrumentation , 1988 .
[269] T. Schødt,et al. Effect of magnesium supplementation on blood pressure and electrolyte concentrations in hypertensive patients receiving long term diuretic treatment. , 1986, British medical journal.
[270] J. Cruickshank,et al. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen , 1984, British journal of obstetrics and gynaecology.
[272] Jeffrey R. Wilson,et al. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women , 1994, The Lancet.
[273] F M Charbonnier,et al. AAMI/ANSI standard for automatic or advisory external defibrillators. Association for the Advancement of Medical Instrumentation. American National Standards Institute. , 1993, Journal of electrocardiology.
[274] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .
[275] J. Schlesselman,et al. Hormonal contraception and risk of cardiovascular disease. An international perspective. , 1998, Contraception.
[276] Christopher H Schmid,et al. Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.
[277] Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension , 1999 .
[278] Effects of replacing sodium intake in subjects on a low sodium diet: a crossover study. Australian National Health & Medical Research Council Dietary Salt Study Management Committee. , 1989, Clinical and experimental hypertension. Part A, Theory and practice.
[279] L. Lind,et al. Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. , 1991, American journal of hypertension.
[280] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[281] R. Grubb,et al. Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association , 2003, Stroke.
[282] L. Appel,et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. , 1999, Archives of internal medicine.
[283] G. Bray,et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet , 2001 .
[284] G. Stergiou,et al. Clinic, home and ambulatory pulse pressure: comparison and reproducibility , 2002, Journal of hypertension.
[285] J. Staessen. Treatment of isolated systolic hypertension , 1998 .
[286] A. Avenell,et al. Systematic review of randomised controlled trials , 2018 .
[287] S. Yusuf,et al. Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53. , 2000 .
[288] Leandro Provinciali,et al. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .
[289] S. Kennedy,et al. Atenolol in essential hypertension during pregnancy , 1991 .
[290] L. Iacoviello,et al. Controlled trial of long term oral potassium supplements in patients with mild hypertension. , 1987, British medical journal.
[291] L. Poston,et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society , 1999, Journal of Human Hypertension.
[292] A. Chobanian,et al. National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence. , 2000, Hypertension.
[293] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[294] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[295] A. Zanchetti,et al. Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials? , 2002, Journal of hypertension.
[296] I. Kuwajima,et al. Is white coat hypertension innocent? Structure and function of the heart in the elderly. , 1993, Hypertension.
[297] Alan D. Lopez,et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. , 1997, The New England journal of medicine.
[298] A. Farmer,et al. Within‐patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine , 1994, Journal of hypertension.
[299] P. Millard,et al. Effect of reduced dietary sodium on blood pressure. , 1996, The Journal of family practice.
[300] L. Niskanen,et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.
[301] L. Monnier,et al. Influence of Indigestible Fibers on Glucose Tolerance , 1978, Diabetes Care.
[302] Barry R. Davis,et al. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). , 2002, JAMA.
[303] Eoin O'Brien,et al. ABC of Hypertension , 1981 .
[304] Yutaka Imai,et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement , 2003, Journal of hypertension.
[305] A. Zanchetti,et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. , 2001, Journal of the American Society of Nephrology : JASN.
[306] N. Chapman,et al. Ethnic differences in the hypertensive heart and 24-hour blood pressure profile. , 1998, Hypertension.
[307] J. Cruickshank,et al. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. , 1985, British journal of obstetrics and gynaecology.
[308] Morris J. Brown,et al. Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs , 2002, Journal of hypertension.
[309] Lippincott Williams Wilkins,et al. 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. , 1993, Hypertension.
[310] S. Lewington. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .
[311] T. Wilt,et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.
[312] J. Slattery,et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.
[313] T. Hedner,et al. Smoking affects blood pressure. , 1996, Blood pressure.
[314] D. Mant,et al. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation , 1994, The Lancet.
[315] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[316] P. Primatesta,et al. Blood pressure levels and hypertension status among ethnic groups in England , 2000, Journal of Human Hypertension.
[317] A. Zanchetti,et al. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study , 2001, Journal of hypertension.
[318] R. Holman,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .
[319] T. Beard. PRIMARY PREVENTION OF HYPERTENSION , 1983, The Lancet.
[320] A. Logan,et al. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. , 1996, JAMA.
[321] Sue Ziebland,et al. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study , 1995, BMJ.
[322] B. Sibai,et al. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. , 1984, American journal of obstetrics and gynecology.
[323] K. Anderson,et al. An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.
[324] S. Parker,et al. A Prospective Study of Primary and Secondary Risk Factor Management in Stroke Patients , 1995, Journal of the Royal College of Physicians of London.
[325] L. Appel,et al. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. , 2000, American journal of hypertension.
[326] C. Schmid,et al. Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease , 2001, Annals of Internal Medicine.
[327] T. Hedner,et al. Survival in treated hypertension: follow up study after two decades , 1998, BMJ.
[328] P. Macfarlane,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.
[329] R B Haynes,et al. A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction. , 2000, Archives of internal medicine.
[330] B. Davis,et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.
[331] J. Bosch,et al. Use of ramipril in preventing stroke: double blind randomised trial , 2002, BMJ : British Medical Journal.
[332] M. Nieminen,et al. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study , 2002, Journal of hypertension.
[333] J. Mason,et al. North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care , 1998 .
[334] N. Shulman,et al. Renal vascular disease in African-Americans and other racial minorities. , 1991, Circulation.
[335] M. Woodward,et al. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .
[336] J. Chalmers,et al. Australian National Health and Medical Research Council dietary salt study in mild hypertension. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[337] A. Sherwood,et al. Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning. , 2000, Archives of Internal Medicine.
[338] Validation of the SpaceLabs 90207 ambulatory blood pressure monitor for use in pregnancy. , 1993, British journal of obstetrics and gynaecology.
[339] H. Parving,et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.
[340] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .
[341] C. Redman,et al. Antihypertensive drugs in pregnancy. , 1985, Clinics in perinatology.
[342] B. Williams. Hypertension in diabetes , 2003, Handbook of Diabetes.
[343] P. Sever,et al. Concomitant risk factors in hypertensives: a survey of risk factors for cardiovascular disease amongst hypertensives in English general practices. , 1996, Blood pressure.
[344] C. Power,et al. U-shaped relation for alcohol consumption and health in early adulthood and implications for mortality , 1998, The Lancet.
[345] A. Silman,et al. EVALUATION OF THE EFFECTIVENESS OF A LOW SODIUM DIET IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION , 1983, The Lancet.
[346] B. Sibai,et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 1998, The New England journal of medicine.
[347] P. Whelton,et al. What is the role of dietary sodium and potassium in hypertension and target organ injury? , 1999, The American journal of the medical sciences.
[348] L. Passman,et al. The treatment of mild hypertension study. , 1993, JAMA.
[349] C. Bulpitt,et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. , 1999, The New England journal of medicine.
[350] E. O’Brien,et al. An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. , 1993, Journal of hypertension.
[351] S. Shapiro,et al. The risk of myocardial infarction after quitting smoking in men under 55 years of age. , 1985, The New England journal of medicine.
[352] R. West,et al. Smoking cessation: evidence based recommendations for the healthcare system , 1999, BMJ.
[353] C. Schmid,et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. , 2001, Annals of internal medicine.
[354] M. J. Ashby,et al. Optimisation of antihypertensive treatment by crossover rotation of four major classes , 1999, The Lancet.
[355] M. Cooper,et al. Pathogenesis, prevention, and treatment of diabetic nephropathy , 1998, The Lancet.
[356] J. Grimshaw,et al. North of England evidence based guidelines development project: methods of guideline development , 1996, BMJ.
[357] A. Hofman,et al. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. , 1994, The American journal of clinical nutrition.
[358] B. Levine,et al. Comparison of single versus multiple lifestyle interventions: are the antihypertensive effects of exercise training and diet-induced weight loss additive? , 1997, The American journal of cardiology.
[359] Pettinger Wa,et al. Single-drug therapy for hypertension in men. , 1993 .
[360] ECiM 6BQ,et al. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. , 1992, BMJ.
[362] U. Goldbourt,et al. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. , 1998, JAMA.
[363] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[364] M. Kikuya,et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study , 2000, Journal of hypertension.
[365] L. Poston,et al. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. , 2002, American journal of obstetrics and gynecology.
[366] T. Olsen,et al. Effect of blood pressure and diabetes on stroke in progression , 1994, The Lancet.
[367] J. Fuller,et al. Lisinopril and albumin excretion in diabetes , 1997, The Lancet.
[368] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[369] P. Whelton,et al. Combinations of potassium, calcium, and magnesium supplements in hypertension. , 1995, Hypertension.
[370] R. T. Lie,et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. , 2001, BMJ : British Medical Journal.